MXPA04004064A - Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion. - Google Patents

Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion.

Info

Publication number
MXPA04004064A
MXPA04004064A MXPA04004064A MXPA04004064A MXPA04004064A MX PA04004064 A MXPA04004064 A MX PA04004064A MX PA04004064 A MXPA04004064 A MX PA04004064A MX PA04004064 A MXPA04004064 A MX PA04004064A MX PA04004064 A MXPA04004064 A MX PA04004064A
Authority
MX
Mexico
Prior art keywords
inflammation
carboxamide derivatives
treatment
heteroaromatic carboxamide
heteroaromatic
Prior art date
Application number
MXPA04004064A
Other languages
English (en)
Spanish (es)
Inventor
Thao D Perry
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of MXPA04004064A publication Critical patent/MXPA04004064A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
MXPA04004064A 2001-10-30 2002-10-30 Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion. MXPA04004064A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34081601P 2001-10-30 2001-10-30
PCT/US2002/034801 WO2003037886A2 (fr) 2001-10-30 2002-10-30 Derives de carboxamide heteroaromatique destines au traitement des inflammations

Publications (1)

Publication Number Publication Date
MXPA04004064A true MXPA04004064A (es) 2004-09-06

Family

ID=23335051

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004064A MXPA04004064A (es) 2001-10-30 2002-10-30 Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion.

Country Status (7)

Country Link
EP (1) EP1444010A2 (fr)
JP (1) JP2005509645A (fr)
AU (1) AU2002356871A1 (fr)
BR (1) BR0213734A (fr)
CA (1) CA2464924A1 (fr)
MX (1) MXPA04004064A (fr)
WO (1) WO2003037886A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ537394A (en) 2002-06-06 2006-12-22 Boehringer Ingelheim Pharma Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
JP2006512313A (ja) 2002-10-31 2006-04-13 アムジェン インコーポレイテッド 抗炎症剤
CA2534127A1 (fr) * 2003-07-31 2005-02-10 Boehringer Ingelheim Pharmaceuticals, Inc. Composes de benzothiophene substitues et utilisations
FR2860792B1 (fr) * 2003-10-10 2006-02-24 Sanofi Synthelabo Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
WO2005056562A1 (fr) 2003-12-05 2005-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Composes amide d'acide 3-amino-thieno[2,3-b] pyridine-2-carboxylique substitue servant d'inhibiteurs d'ikk
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
AU2005228899A1 (en) 2004-03-30 2005-10-13 Novartis Vaccines And Diagnostics, Inc. Substituted thiophene derivatives as anti-cancer agents
PE20060373A1 (es) 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
MX2007012116A (es) 2005-03-29 2008-04-08 Icos Corp Derivados de heteroaril urea utiles para inhibir chk1.
GB0507200D0 (en) * 2005-04-08 2005-05-18 Smithkline Beecham Corp Chemical compounds
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
KR20080021077A (ko) 2005-06-30 2008-03-06 스미스클라인 비참 코포레이션 화합물
CA2637335A1 (fr) 2006-01-23 2007-08-02 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides utiles en tant qu'inhibiteurs de proteines kinases
JP2009533452A (ja) 2006-04-13 2009-09-17 バーテックス ファーマシューティカルズ インコーポレイテッド タンパク質キナーゼの阻害剤として有用なチオフェン−カルボキサミド
MX2008013584A (es) 2006-04-26 2009-03-23 Genentech Inc Compuestos farmaceuticos.
US8853244B2 (en) 2006-05-23 2014-10-07 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
CN101495474A (zh) 2006-05-23 2009-07-29 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的噻吩-甲酰胺类
CA2653654A1 (fr) 2006-06-06 2007-12-21 Boehringer Ingelheim International Gmbh Composes amide de l'acide 3-amino-thieno[2,3-b]pyridine-2-carboxylique substitues, procedes de preparation et leurs utilisations
WO2008020622A1 (fr) * 2006-08-17 2008-02-21 Kyorin Pharmaceutical Co., Ltd. NOUVEAU COMPOSÉ DE THIÉNO[2,3-d]PYRIMIDINE
PE20081679A1 (es) 2006-12-07 2008-12-18 Hoffmann La Roche Compuestos del inhibidor de fosfoinositida 3-cinasa y metodos de uso
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
US7893059B2 (en) 2007-09-24 2011-02-22 Genentech, Inc. Thiazolopyrimidine PI3K inhibitor compounds and methods of use
WO2009085983A1 (fr) 2007-12-19 2009-07-09 Genentech, Inc. 5-anilinoimidazopyridines et procédés d'utilisation
WO2009082687A1 (fr) 2007-12-21 2009-07-02 Genentech, Inc. Azaindolizines et procédés d'utilisation
BRPI1008749B8 (pt) 2009-02-05 2021-05-25 Immunogen Inc compostos derivados de benzodiazepina, seus conjugados, composição farmacêutica, seu uso e seus processos de preparação
WO2010102968A1 (fr) 2009-03-10 2010-09-16 Glaxo Group Limited Dérivés d'indole comme inhibiteurs de ikk2
CA2753285A1 (fr) 2009-03-12 2010-09-16 Genentech, Inc. Combinaisons de composes inhibiteurs de phosphoinositide 3-kinase et d'agents chimiotherapeutiques pour le traitement de tumeurs malignes hematopoietiques
JP2012524066A (ja) * 2009-04-16 2012-10-11 テリック,インコーポレイテッド チューブリン重合阻害剤としての置換4−アミノ−5−ベンゾイル−2−(フェニルアミノ)チオフェン−3−カルボニトリルおよび置換4−アミノ−5−ベンゾイル−2−(フェニルアミノ)チオフェン−3−カルボキサミド
BR112012006802A2 (pt) 2009-09-28 2020-08-18 F.Hoffmann-La Roche Ag composto, composição farmacêutica, método para tratar câncer, usos de um composto, kit e invenção
WO2011049625A1 (fr) 2009-10-20 2011-04-28 Mansour Samadpour Procédé de criblage d'aflatoxine dans des produits
JP5889795B2 (ja) 2009-11-05 2016-03-22 ライゼン・ファーマシューティカルズ・エスアー 新規キナーゼモジュレーター
MX341687B (es) 2010-02-10 2016-08-30 Immunogen Inc "anticuerpos cd20 y su utilización".
EP3666289A1 (fr) 2011-02-15 2020-06-17 ImmunoGen, Inc. Dérivés de benzodiazépine cytotoxique
PT2705029T (pt) 2011-05-04 2019-02-01 Rhizen Pharmaceuticals S A Novos compostos como moduladores de proteína quinases
KR101909801B1 (ko) 2012-06-08 2018-10-18 에프. 호프만-라 로슈 아게 암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물
HUE034591T2 (en) 2012-07-04 2018-02-28 Rhizen Pharmaceuticals S A Selective PI3K delta inhibitors
EP2887965A1 (fr) 2012-08-22 2015-07-01 ImmunoGen, Inc. Dérivés de benzodiazépine cytotoxique
WO2014134483A2 (fr) 2013-02-28 2014-09-04 Immunogen, Inc. Conjugués comprenant des agents de liaison cellulaire (cba) et des agents cytotoxiques
US9901647B2 (en) 2013-02-28 2018-02-27 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014194030A2 (fr) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugués comprenant des agents de liaison cellulaire et des agents cytotoxiques
AR104068A1 (es) 2015-03-26 2017-06-21 Hoffmann La Roche Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
EP3507305A1 (fr) 2016-09-02 2019-07-10 Dana-Farber Cancer Institute, Inc. Composition et méthodes de traitement des déreglements des lymphocytes b
WO2018204775A1 (fr) 2017-05-05 2018-11-08 Hepanova, Inc. Composés amino-aryl-benzamide et leurs procédés d'utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1360982A (en) * 1970-08-27 1974-07-24 Beecham Group Ltd Derivatives of 1-phenyl-5-aminoimidazole and compositions thereof
US3864359A (en) * 1972-05-01 1975-02-04 American Cyanamid Co 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof
US4264495A (en) * 1972-05-15 1981-04-28 Eastman Kodak Company 2-Thienyl azo dyestuff compounds
GB1468012A (en) * 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DD236530A1 (de) * 1985-04-26 1986-06-11 Univ Halle Wittenberg Verfahren zur herstellung von 2-cyano-2-(4h-4-oxo-1,2,dihydro-thieno 2,3-d 1,3 thiazin-2-yliden)-essigsaeureestern
DD263055A1 (de) * 1987-07-28 1988-12-21 Univ Dresden Tech Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene
DE3914430A1 (de) * 1988-05-05 1989-11-16 Ciba Geigy Ag Azofarbstoffe, verfahren zu deren herstellung und deren verwendung
DE4019168A1 (de) * 1989-06-19 1990-12-20 Ciba Geigy Ag Azofarbstoffe, deren herstellung und verwendung
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
JP2002105081A (ja) * 2000-07-28 2002-04-10 Nikken Chem Co Ltd 新規チオフェンニ環化合物
AU2002211663A1 (en) * 2000-10-12 2002-04-22 Smith Kline Beecham Corporation Nf-$g(k)b inhibitors
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
WO2003028731A1 (fr) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Inhibiteurs de kinase chk1

Also Published As

Publication number Publication date
EP1444010A2 (fr) 2004-08-11
AU2002356871A1 (en) 2003-05-12
CA2464924A1 (fr) 2003-05-08
BR0213734A (pt) 2004-10-19
WO2003037886A2 (fr) 2003-05-08
JP2005509645A (ja) 2005-04-14
WO2003037886A3 (fr) 2003-12-24

Similar Documents

Publication Publication Date Title
MXPA04004064A (es) Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion.
MXPA04002070A (es) Compuestos de indazol sustituidos para el tratamiento de la inflamacion.
MXPA04002682A (es) Compuestos pirazolilo sustituidos para el tratamiento de la inflamacion.
WO2003024935A3 (fr) Composes de pyrazolyle substitues destines au traitement de l'inflammation
WO2003027075A3 (fr) Composes substitues de sulfamide benzene de pyrazolyl destines au traitement des inflammations
TW200510416A (en) P38 inhibitors and methods of use thereof
HK1053989A1 (en) Fused pyrrolocarbazoles against inflammation
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
WO2004041203A3 (fr) Promedicaments de gemcitabine, leurs compositions pharmaceutiques et leurs utilisations
MY131518A (en) 6-substituted pyrido-pyrimidines
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EP1463733A4 (fr) Inhibiteurs de kinesine mitotique
HK1080466A1 (zh) 用於治療過度增生疾病的稠合三環雜環
PL351125A1 (en) Derivatives of 4,5-diaryl-3(2)-furanone as inhibitors of cykoxygenease-2
AU2003209118A1 (en) Aryl ureas as kinase inhibitors
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
GB0111186D0 (en) Novel compounds
TNSN04015A1 (en) Combination therapy for the treatment of cancer
SG149045A1 (en) Novel fused pyrrolocarbazoles
AU2002367172A1 (en) 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
MY149041A (en) Novel fused pyrrolocarbazoles
MXPA03007653A (es) Uso de lp82 para tratar trastornos hematopoyeticos.
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
CA2485298A1 (fr) Composes substitues de pyrazolyl utilises dans le traitement des inflammations
AUPS234402A0 (en) Anti-tumour polycyclic carboxamides